Revelation Biosciences, Inc. engages in the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Revelation Biosciences Inc market cap is $2.52M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Revelation Biosciences Inc 52 week high is $40.60 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Revelation Biosciences Inc 52 week low is $3.08 as of November 20, 2026.
Revelation Biosciences Inc stock price today is $3.50.
Revelation Biosciences Inc stock price yesterday was $3.69.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Revelation Biosciences Inc's P/E ratio is -0.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Revelation Biosciences Inc P/B ratio is 0.3486.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Revelation Biosciences Inc 50-day moving average is $4.90.